Richard Ashdown, Amplia Group; Catherine Skobe, Pfizer; Simon Fry, Springer Healthcare The impact of the COVID-19 global pandemic on healthcare systems, colleagues, friends, and loved ones has been unprecedented and, in many cases, tragic. In thinking about digital...
Gretchen Chidester, PhD, MedThink SciCom; Alexandra Traut, PhD, AbbVie When developing a scientific communication platform (SCP), are you considering whether it will be relevant to workstreams and stakeholders worldwide? The overarching story described within an SCP...
Allison M. Galway, MS, ISMPP CMPP™, Chameleon Communications International, Inc.*, New York, NY, USA; Sandra Harris, PhD, ISMPP CMPP™, ProEd Communications Inc.*, Beachwood, OH, USA; Dina Marenstein, PhD, ISMPP CMPP™, Chameleon Communications International, Inc.*, New...
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
Orla Weir, BSc (Hons), CIM DipM, CMC Connect, McCann Health Medical Communications, Macclesfield, UK; Ged Forshaw, APS, Manchester, UK; Andy Stewart, BSc (Hons), APS, Manchester, UK Do you need or want to make your meeting completely or partly virtual? Are you worried...
